DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Carboplatin (Carboplatin) - Thrombocytopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Thrombocytopenia (125)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 125   Next >>

Possible Carboplatin side effects in male

Reported by a physician from France on 2012-08-24

Patient: male

Reactions: Dermatitis Acneiform, Renal Failure, Neoplasm Malignant, Dehydration, Purpura, Neutropenia, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer

Carboplatin
    Dosage: 200 df, unknown/d
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-08-03

Pemetrexed Disodium
    Dosage: 200 df, unknown/d
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-08-03

Erlotinib Hydrochloride
    Dosage: 150 mg, uid/qd
    Administration route: Oral
    Start date: 2012-08-17



Possible Carboplatin side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)

Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Prednisolone
    Dosage: 1mg/kg x 1/2 week
    Start date: 2011-12-13
    End date: 2011-12-14

Adriamycin PFS
    Dosage: 30 mg/m2 x 1/4 week
    Start date: 2011-03-16

Prednisolone
    Dosage: 40 mg/m2 x 1/4 week
    Administration route: Oral
    Start date: 2011-03-16

Prednisolone
    Dosage: 2 mg/m2, 1x/day
    Administration route: Oral
    Start date: 2011-03-24

Vindesine Sulfate
    Dosage: 2.4 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Carboplatin
    Dosage: 250 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 350 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Etoposide
    Dosage: 100 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-24

Vincristine Sulfate
    Dosage: 1 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Ranimustine
    Dosage: 60 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-16

Adriamycin PFS
    Dosage: 40 mg/m2 x 1/4 week
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2011-03-09

Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium



Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-08-23

Patient: female, weighing 70.0 kg (154.0 pounds)

Reactions: Weight Decreased, Escherichia Test Positive, Malaise, Vomiting, Nausea, Dysuria, Clostridium Difficile Colitis, Culture Urine Positive, Thrombocytopenia, Enterobacter Test Positive

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Taxol
    Dosage: 299 mg

Carboplatin
    Dosage: 376 mg



Possible Carboplatin side effects in female

Reported by a physician from Germany on 2012-08-23

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Placebo
    Indication: Breast Cancer
    Start date: 2012-04-25

Docetaxel
    Indication: Breast Cancer
    Start date: 2012-04-25

Herceptin
    Indication: Breast Cancer
    Start date: 2012-04-25

Herceptin

Carboplatin
    Dosage: 5 auc
    Indication: Breast Cancer
    Start date: 2012-04-25

Other drugs received by patient: Metoprolol Tartrate



Possible Carboplatin side effects in male

Reported by a physician from Hungary on 2012-08-22

Patient: male, weighing 74.0 kg (162.8 pounds)

Reactions: Pneumonia, Anaemia, Granulocytopenia, Neutropenia, Thrombocytopenia, Leukopenia, Infectious Pleural Effusion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Gemcitabine Hydrochloride
    Dosage: last dose prior to sae: 01 april 2010

Carboplatin
    Dosage: last dose prior to event on 25 january 2010.

Gemcitabine Hydrochloride

Gemcitabine Hydrochloride
    Dosage: freq: day 1 + 8 every 3 weeks

Carboplatin
    Dosage: form: infusion;
    Indication: non-Small Cell Lung Cancer

Carboplatin
    Dosage: last dose prior to sae: 23 march 2010, frequency: 1xdaily

Avastin
    Dosage: frequency: 1x, form infusion;
    Indication: non-Small Cell Lung Cancer

Gemcitabine Hydrochloride
    Dosage: last dose of iv gemcitabine prior to event on 25 january 2010.

Avastin
    Dosage: frequency as per protocol, last dose of prior to event on 25 january 2010. form infusion

Gemcitabine Hydrochloride
    Dosage: freq: day 1 + 8 every 3 weeks

Avastin
    Dosage: last dose prior to sae: 16 february 2010. last dose prior to leukopenia was 23 mar 2010

Gemcitabine Hydrochloride
    Dosage: form infusion, on day 1 and day 8; frequency: 1xdaily;
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-11-09
    End date: 2009-11-17

Gemcitabine Hydrochloride
    Dosage: frequency: 2xevery three week, form: infusion

Carboplatin

Avastin
    Dosage: last dose prior to sae: 16 february 2010,infusion, frequency: 1xdaily

Other drugs received by patient: Fluticasone Propionate / Salmeterol; Augmentin '500'; Kalium-R; Sinecod; Ondansetron; Bisoprolol Fumarate; Pegfilgrastim; Lidocaine; Ciprofloxacin Hydrochloride; Neupogen; Spiriva; Kalium-R; Eprex; Neorecormon; Hydromorphone HCL; Berodual; Fluticasone Propionate / Salmeterol; Neorecormon; Augmentin '500'; Kalium-R; Medrol; Medrol; Neupogen; Medrol; Bisoprolol Fumarate; Spiriva; Megesin; Megesin



Possible Carboplatin side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient: 44 year old female

Reactions: Squamous Cell Carcinoma, Carbohydrate Antigen 125 Increased, Thrombocytopenia

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: maintenance dose for a total cumulative dose of 1.696 mg
    Indication: Ovarian Cancer
    End date: 2010-04-01

Carboplatin
    Dosage: x 3 days for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2007-07-13
    End date: 2007-09-14

Topotecan Hydrochloride
    Start date: 2005-08-29

Cisplatin
    Dosage: x 3 days for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2005-06-14
    End date: 2005-08-10

Topotecan Hydrochloride
    Dosage: for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2005-06-14
    End date: 2005-08-02

Doxorubicin Hydrochloride
    Dosage: 3 cycles given
    Start date: 2007-07-13
    End date: 2007-09-14

ABT-888
    Administration route: Oral
    Indication: Ovarian Cancer
    Start date: 2010-06-01
    End date: 2011-04-01

Cyclophosphamide
    Indication: Ovarian Cancer
    Start date: 2010-06-01
    End date: 2011-04-01

Paclitaxel
    Dosage: x 3 days for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2007-07-13
    End date: 2007-09-14



Possible Carboplatin side effects in 71 year old male

Reported by a physician from Japan on 2012-08-14

Patient: 71 year old male, weighing 45.0 kg (99.0 pounds)

Reactions: Haemoglobin Decreased, Diarrhoea, Febrile Neutropenia, Gastroenteritis Staphylococcal, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Irinotecan Hydrochloride
    Dosage: 70 mg, single
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2011-12-21
    End date: 2011-12-21

Irinotecan Hydrochloride
    Dosage: 60 mg, single
    Start date: 2012-03-06
    End date: 2012-03-06

Carboplatin
    Dosage: 220 mg, single
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2011-12-21
    End date: 2011-12-21

Irinotecan Hydrochloride
    Dosage: 60 mg, single
    Start date: 2012-02-28
    End date: 2012-02-28

Carboplatin
    Dosage: 210 mg, single
    Start date: 2012-02-28
    End date: 2012-02-28

Carboplatin
    Dosage: 220 mg, single
    Start date: 2012-01-20
    End date: 2012-01-20

Irinotecan Hydrochloride
    Dosage: 70 mg, single
    Start date: 2011-12-28
    End date: 2011-12-28

Irinotecan Hydrochloride
    Dosage: 70 mg, single
    Start date: 2012-01-20
    End date: 2012-01-20

Irinotecan Hydrochloride
    Dosage: 70 mg, single
    Start date: 2012-01-27
    End date: 2012-01-27

Other drugs received by patient: NEU-UP; Ambisome; Lansoprazole; Decadron Phosphate; Vancomycin Hydrochloride; Zyvox; Kremezin; Platelets, Human Blood; Allopurinol; Maxipime; Loperamide Hydrochloride; Itraconazole; Targocid; Meropenem; BIO Three; Gran; Medrol



Possible Carboplatin side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-14

Patient: 72 year old male

Reactions: Pneumonia, Hypotension, Febrile Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Etoposide
    Dosage: 50 mg/m2 on day1 and 3
    Indication: Small Cell Lung Cancer Stage Unspecified

Carboplatin
    Dosage: 300 mg/m2 on day1
    Indication: Small Cell Lung Cancer Stage Unspecified



Possible Carboplatin side effects in

Reported by a physician from United States on 2012-08-13

Patient:

Reactions: Thrombosis, Pneumonia, Haemorrhage, Anaemia, Procedural Site Reaction, Ulcer Haemorrhage, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 812 mg
    End date: 2012-07-10

Fluorouracil
    Dosage: 7160 mg
    End date: 2012-07-14



Possible Carboplatin side effects in 72 year old male

Reported by a consumer/non-health professional from Japan on 2012-08-08

Patient: 72 year old male

Reactions: Pneumonia, Hypotension, Febrile Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Carboplatin
    Dosage: 300 mg/m2, on day 1
    Indication: Small Cell Lung Cancer Stage Unspecified

Etoposide
    Dosage: 50 mg/m2, on days 1 and 3
    Indication: Small Cell Lung Cancer Stage Unspecified



Possible Carboplatin side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-03

Patient: 72 year old male

Reactions: Pneumonia, Neoplasm Malignant, Hypotension, Febrile Neutropenia, Thrombocytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Etoposide
    Dosage: on day1 + 3
    Indication: Small Cell Lung Cancer Stage Unspecified

Carboplatin
    Dosage: on day1
    Indication: Small Cell Lung Cancer Stage Unspecified



Possible Carboplatin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient: female

Reactions: Hypophosphataemia, Fatigue, Tinnitus, Clostridium Difficile Colitis, Neutropenia, Thrombocytopenia, Klebsiella Bacteraemia

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Ovarian Cancer

Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Malignant Peritoneal Neoplasm

Carboplatin
    Dosage: auc 7 reconstituted with one liter normal saline (day 1;repeated every 21 days),intraperitoneal
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
    Indication: Ovarian Cancer

Paclitaxel
    Dosage: 60 mg/m2 reconstituted with one liter normal saline (day 8; repeated every 21 days),intraperitoneal
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
    Indication: Fallopian Tube Cancer

Paclitaxel
    Dosage: 175 mg/m2 (day 1;repeated every 21 days),intravenous
    Indication: Ovarian Cancer



Possible Carboplatin side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-17

Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Hypotension, Disseminated Intravascular Coagulation, Headache, Malaise, Sepsis, Neutropenia, Cardiac Arrest, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Carboplatin
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-04

Etoposide
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-06

Other drugs received by patient: Aldactone; Urief; Warfarin Sodium; Alendronate Sodium; Spiriva; Magnesium Oxide; Theophylline; Ambroxol Hydrochloride; Enalapril Maleate; Seltepnon; Vasolator; Sotalol Hydrochloride



Possible Carboplatin side effects in 64 year old female

Reported by a physician from France on 2012-07-16

Patient: 64 year old female, weighing 54.0 kg (118.8 pounds)

Reactions: Muscle Atrophy, Neutropenia, Polyarthritis, Thrombocytopenia, Paraesthesia

Drug(s) suspected as cause:
Taxotere
    Dosage: dose: 4 cycles at 120 mg every 3 weeks
    Indication: Bronchial Carcinoma
    Start date: 2011-03-28
    End date: 2011-06-03

Carboplatin
    Indication: Bronchial Carcinoma
    End date: 2011-06-01



Possible Carboplatin side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-13

Patient: male

Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in male

Reported by a physician from Italy on 2012-07-11

Patient: male

Reactions: Liver Function Test Abnormal, Neutropenia, Thrombocytopenia, Haemolysis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in female

Reported by a consumer/non-health professional from Italy on 2012-06-27

Patient: female

Reactions: Respiratory Failure, Neutropenia, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in 76 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-18

Patient: 76 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Malaise, Hypotension, Disseminated Intravascular Coagulation, Neutropenia, Headache, Thrombocytopenia, Cardiac Arrest

Adverse event resulted in: death

Drug(s) suspected as cause:
Etoposide
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-06

Carboplatin
    Dosage: dose unit: unknown
    Indication: Small Cell Lung Cancer Stage Unspecified
    Start date: 2010-10-04
    End date: 2010-10-04

Other drugs received by patient: Sotalol Hydrochloride; Ambroxol Hydrochloride; Seltepnon; Enalapril Maleate; Magnesium Oxide; Carvedilol; Alendronate Sodium; Spiriva; Furosemide; Warfarin Sodium; Theophylline; Aldactone; Urief; Vasolator



Possible Carboplatin side effects in

Reported by a individual with unspecified qualification from United States on 2012-06-18

Patient:

Reactions: Thrombosis, Confusional State, Pain, Fatigue, Thrombocytopenia, Decreased Appetite, Arterial Thrombosis, Vomiting, Dyspnoea, Nausea, Lymphopenia, Anaemia, Hyponatraemia, Pulmonary Haemorrhage, Diarrhoea, Dehydration, Neutropenia, Hypertension, Infection

Drug(s) suspected as cause:
Carboplatin
    Dosage: auc 6
    Indication: non-Small Cell Lung Cancer

Bortezomib and Bortezomib
    Dosage: 1.3, 1.6 and 1.8 mg/square meter weekly on day 1 and day 8 of every 3 week cycle
    Indication: non-Small Cell Lung Cancer

Avastin
    Indication: non-Small Cell Lung Cancer



Possible Carboplatin side effects in male

Reported by a physician from Italy on 2012-06-14

Patient: male

Reactions: Epstein-Barr Virus Infection, Anaemia, Cytomegalovirus Infection, Neutropenia, Thrombocytopenia, Disease Progression, Infection

Drug(s) suspected as cause:
Carmustine
    Indication: Burkitt's Lymphoma

Carboplatin
    Indication: Burkitt's Lymphoma

Rituximab
    Indication: Burkitt's Lymphoma

Etoposide
    Indication: Burkitt's Lymphoma

Cytarabine
    Indication: Burkitt's Lymphoma

Vincristine
    Indication: Burkitt's Lymphoma

Melphalan Hydrochloride
    Indication: Burkitt's Lymphoma

Radiotherapy
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Indication: Burkitt's Lymphoma

Cisplatin
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Indication: Burkitt's Lymphoma

Methotrexate
    Indication: Burkitt's Lymphoma

Ifosfamide
    Indication: Burkitt's Lymphoma

Granulocyte Colony Stimulating Factor
    Indication: Burkitt's Lymphoma

Methylprednisolone
    Indication: Burkitt's Lymphoma

Unknown Medication
    Dosage: antimicrobial prophylaxis
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication



Possible Carboplatin side effects in male

Reported by a physician from United States on 2012-06-13

Patient: male, weighing 85.3 kg (187.7 pounds)

Reactions: Respiratory Failure, Sepsis, Thrombocytopenia, Renal Failure Acute, Leukopenia, Infectious Peritonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 6 df, q21d
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-09-04
    End date: 2009-09-04

Pemetrexed Disodium
    Dosage: 500 mg/m2, q21d
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-09-04
    End date: 2009-09-04

Avastin
    Dosage: 15 mg/m2, q21d
    Indication: non-Small Cell Lung Cancer
    Start date: 2009-09-04
    End date: 2009-09-04

Other drugs received by patient: Folic Acid; Duragesic-100; Vitamin B-12; Megestrol Acetate; Dexamethasone; Nexium; Fluconazole; Norco



Possible Carboplatin side effects in female

Reported by a physician from Korea, Republic of on 2012-06-12

Patient: female

Reactions: Stomatitis, Vomiting, Gastrointestinal Haemorrhage, Nausea, Alanine Aminotransferase Increased, Anaemia, Febrile Neutropenia, Impaired Healing, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Carboplatin
    Indication: Breast Cancer

Avastin
    Indication: Breast Cancer

Docetaxel
    Indication: Breast Cancer



Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-06-07

Patient: female, weighing 150.6 kg (331.2 pounds)

Reactions: Diarrhoea, Sepsis, Neutropenia, Thrombocytopenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Carboplatin

Taxol
    Dosage: 80 mg/m2, unk
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-05-18
    End date: 2012-05-18

Afinitor
    Dosage: 5 mg, qw3 (m, w, f) all 4 weeks, repeat q28 days
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-05-21
    End date: 2012-05-25

Bevacizumab
    Dosage: 10 mg/kg, qd
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-05-18
    End date: 2012-05-18



Possible Carboplatin side effects in female

Reported by a physician from United States on 2012-06-07

Patient: female, weighing 150.6 kg (331.2 pounds)

Reactions: Diarrhoea, Sepsis, Neutropenia, Thrombocytopenia, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 mg/kg, qd
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-05-18
    End date: 2012-05-18

Afinitor
    Dosage: 5 mg, qw3 (m, w, f) all 4 weeks, repeat q28 days
    Administration route: Oral
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-05-21
    End date: 2012-05-25

Taxol
    Dosage: 80 mg/m2, unk
    Indication: Metastatic Malignant Melanoma
    Start date: 2012-05-18
    End date: 2012-05-18

Carboplatin



Possible Carboplatin side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-05

Patient: 44 year old female

Reactions: Squamous Cell Carcinoma, Carbohydrate Antigen 125 Increased, Thrombocytopenia

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: maintenance dose for a total cumulative dose of 1.696 mg
    Indication: Ovarian Cancer
    End date: 2010-04-01

Topotecan
    Start date: 2005-08-29

Doxorubicin HCL
    Dosage: 3 cycles given
    Start date: 2007-07-13
    End date: 2007-09-14

Paclitaxel
    Dosage: x 3 days for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2007-07-13
    End date: 2007-09-14

ABT-888
    Administration route: Oral
    Indication: Ovarian Cancer
    Start date: 2010-06-01
    End date: 2011-04-01

Topotecan
    Dosage: for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2005-06-14
    End date: 2005-08-02

Cyclophosphamide
    Indication: Ovarian Cancer
    Start date: 2010-06-01
    End date: 2011-04-01

Carboplatin
    Dosage: x 3 days for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2007-07-13
    End date: 2007-09-14

Cisplatin
    Dosage: x 3 days for 4 cycles
    Indication: Ovarian Cancer
    Start date: 2005-06-14
    End date: 2005-08-10



Possible Carboplatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-05

Patient: female

Reactions: Confusional State, Respiratory Failure, Hyponatraemia, Neutropenia, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



Possible Carboplatin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-05

Patient: female

Reactions: Vomiting, Wound Dehiscence, Nausea, Pain, Hyperglycaemia, Proteinuria, Ejection Fraction Decreased, Neutropenia, Hypertension, Blood Creatinine Increased, Thrombocytopenia, Infection

Drug(s) suspected as cause:
Herceptin
    Dosage: for 23 weeks

Avastin
    Dosage: for 23 weeks
    Indication: Breast Cancer

Herceptin
    Dosage: loading dose
    Indication: Breast Cancer

Herceptin
    Dosage: total 54 weeks

Paclitaxel
    Dosage: days 1, 8 and 15
    Indication: Breast Cancer

Avastin
    Dosage: total 54 weeks

Carboplatin
    Dosage: auc=6 for 6 cycles
    Indication: Breast Cancer



Possible Carboplatin side effects in 67 year old male

Reported by a consumer/non-health professional from United States on 2012-06-01

Patient: 67 year old male, weighing 155.0 kg (341.0 pounds)

Reactions: Syncope, Anaemia, Dehydration, Haematuria, Thrombocytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: 1df=2.25auc last dose on 27mar2012
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-01-23

Pemetrexed Disodium
    Dosage: 23jan12-12feb12,5mar02-5mar2012(3654d) 188mg/m2:27mar2012
    Indication: non-Small Cell Lung Cancer
    Start date: 2002-03-05

Other drugs received by patient: Folic Acid; Triamterene; Metoprolol Tartrate; Potassium Chloride; Calcium Carbonate; Decadron; Mirtazapine; Vitamin B-12; Magnesium Oxide; Neulasta; Denosumab



Possible Carboplatin side effects in male

Reported by a physician from Italy on 2012-05-31

Patient: male

Reactions: Mucosal Inflammation, Pneumonia, Bone Marrow Failure, Pyrexia, Neutropenia, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2011-11-23
    End date: 2011-11-25

Carboplatin
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2011-11-23
    End date: 2011-11-25

Etoposide
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2011-11-23
    End date: 2011-11-25

Mabthera
    Indication: non-Hodgkin's Lymphoma Recurrent
    Start date: 2011-11-28
    End date: 2011-11-28

Other drugs received by patient: Mesna; Mycostatin; Acetaminophen; Chlorpheniramine TAB; Allopurinol; Ondansetron; Neulasta



Possible Carboplatin side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-29

Patient: female

Reactions: Respiratory Failure, Hyponatraemia, Disorientation, Neutropenia, Thrombocytopenia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017